Cell And Gene Therapy Clinical Trials Market Registering A CAGR Of 22.3% From 2021 To 2028
San Francisco, 6 May 2021: The Report Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, CNS, Cardiology), By Region, And Segment Forecasts, 2021 - 2028 The global cell and gene therapy clinical trials market size is expected to reach USD 45.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.3% from 2021 to 2028. Increasing funding, investments in research and development, and successful product launches are boosting the market growth. Cell and gene therapies (CGTs) signify the next great movement of therapeutic innovation and have resulted in the development of promising therapies around the world. Although a few of the early therapies have got marketing approval in the U.S., there are numerous promising therapies in development across the world. The market of cell and gene ther...